Literature DB >> 2669536

Antidepressant effects of right versus left unilateral ECT and the lateralization theory of ECT action.

R Abrams1, C M Swartz, C Vedak.   

Abstract

In a random-assignment, double-blind, controlled comparison of right versus left unilateral ECT in 30 melancholic men, the two methods were not significantly different in overall antidepressant potency, although there was a significantly faster rate of improvement with left unilateral ECT. These results imply that the antidepressant effects of ECT cannot be attributed primarily to right hemisphere mechanisms, as others have postulated.

Entities:  

Mesh:

Year:  1989        PMID: 2669536     DOI: 10.1176/ajp.146.9.1190

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

1.  Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study.

Authors:  Filip Bouckaert; François-Laurent De Winter; Louise Emsell; Annemieke Dols; Didi Rhebergen; Martien Wampers; Stefan Sunaert; Max Stek; Pascal Sienaert; Mathieu Vandenbulcke
Journal:  J Psychiatry Neurosci       Date:  2016-03       Impact factor: 6.186

2.  The practice of ect in India: ii. The practical administration of ect.

Authors:  C Andrade; A K Agarwal; M V Reddy
Journal:  Indian J Psychiatry       Date:  1993-04       Impact factor: 1.759

3.  Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder.

Authors:  Jennifer S Perrin; Susanne Merz; Daniel M Bennett; James Currie; Douglas J Steele; Ian C Reid; Christian Schwarzbauer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

4.  Follow-up Study on Electroconvulsive Therapy in Treatment-resistant Depressed Patients after Remission: A Chart Review.

Authors:  Yuki Tokutsu; Wakako Umene-Nakano; Takahiro Shinkai; Reiji Yoshimura; Tatsuya Okamoto; Asuka Katsuki; Hikaru Hori; Atsuko Ikenouchi-Sugita; Kenji Hayashi; Kiyokazu Atake; Jun Nakamura
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-04-24       Impact factor: 2.582

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.